Under research, there is also pemvidutide (ALT-801), another GLP-1/glucagon receptor dual agonist, which has been tested primarily in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH) [149]. Here, GCG is linked to metabolic dysfunction-associated steatohepatitis.